دورية أكاديمية
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac
العنوان: | Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac |
---|---|
المؤلفون: | S.R. de Mol van Otterloo, J.M. Westerhoff, T. Leer, R.H.A. Rutgers, L.T.C. Meijers, L.A. Daamen, M.P.W. Intven, H.M. Verkooijen |
المصدر: | Technical Innovations & Patient Support in Radiation Oncology, Vol 29, Iss , Pp 100224- (2024) |
بيانات النشر: | Elsevier, 2024. |
سنة النشر: | 2024 |
المجموعة: | LCC:Medical physics. Medical radiology. Nuclear medicine LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | MR-Linac, MRgRT, Patient reported outcomes, Patient reported experience measures (PREM), Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Background and Purpose: Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients’ pre-treatment expectations of MRgRT are met and reports patients’ on-table experience on a 1.5 T MR-Linac. Materials and methods: All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient’ physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience. Results: We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52–90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients’ expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced. Conclusion: Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2405-6324 |
العلاقة: | http://www.sciencedirect.com/science/article/pii/S2405632423000240Test; https://doaj.org/toc/2405-6324Test |
DOI: | 10.1016/j.tipsro.2023.100224 |
الوصول الحر: | https://doaj.org/article/c6e800c704d4408fa9e812deaee34bfaTest |
رقم الانضمام: | edsdoj.6e800c704d4408fa9e812deaee34bfa |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 24056324 |
---|---|
DOI: | 10.1016/j.tipsro.2023.100224 |